Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 6/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5487402 | 0.98 | ALDH1A1 (0.48) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL27960973 | 0.87 | HCAR2 (0.38) | ALDH1A1TSHRHCAR2DPP4DPP9 | |
| SCHEMBL2734865 | 0.85 | ALDH1A1 (0.52) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL2734881 | 0.85 | ALDH1A1 (0.52) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL7373318 | 0.85 | ALDH1A1 (0.44) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL16330782 | 0.84 | ALDH1A1 (0.47) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL16330780 | 0.84 | ALDH1A1 (0.47) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL856879 | 0.84 | DPP7 (0.50) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| Hydrochloric Acid SCHEMBL7703133 | 0.83 | ALDH1A1 (0.42) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| Hydrochloric Acid SCHEMBL7377199 | 0.83 | ALDH1A1 (0.42) | ALDH1A1ATMTSHRHPGDHCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110000905-A | A kind of heat-barrier material, hot runner plastic injection mould and Shooting Technique | 蓝思科技（长沙）有限公司 | 2019-07-12 | — | — | CN | claimed |
| EP-3604457-B1 | AQUEOUS INK COMPOSITION, INK SET, IMAGE FORMING METHOD, AND RESIN MICROPARTICLES FOR INK | FUJIFILM CORP (JP) | 2022-02-09 | — | — | EP | disclosed |
| US-11092594-B2 | Haptens, hapten conjugates, compositions thereof and method for their preparation and use | VENTANA MEDICAL SYSTEMS, INC. (US) | 2021-08-17 | — | — | US | disclosed |
| EP-3768294-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | Carmot Therapeutics, Inc. (US) | 2021-01-27 | — | — | EP | disclosed |
| EP-3604457-A1 | AQUEOUS INK COMPOSITION, INK SET, IMAGE FORMING METHOD, AND RESIN FINE PARTICLES FOR INKS | FUJIFILM Corporation (JP) | 2020-02-05 | — | — | EP | disclosed |
| EP-3564674-A1 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | Ventana Medical Systems, Inc. (US) | 2019-11-06 | — | — | EP | disclosed |
| WO-2019183577-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | CARMOT THERAPEUTICS, INC. (US) | 2019-09-26 | — | — | WO | disclosed |
| EP-3276349-B1 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | VENTANA MED SYST INC (US) | 2019-08-07 | — | — | EP | disclosed |
| CN-110000905-A | A kind of heat-barrier material, hot runner plastic injection mould and Shooting Technique | 蓝思科技（长沙）有限公司 | 2019-07-12 | — | — | CN | disclosed |
| EP-2389190-B1 | FGF21 DERIVATIVES WITH ALBUMIN BINDER A-B-C-D-E- AND THEIR USE | NOVO NORDISK AS (DK) | 2018-09-19 | — | — | EP | disclosed |
| US-5581002-A | BLOCKING WITH BUTYLDIMETHYLSILANYL CHLORIDE; ALKYLATION; OZONOLYZING WITH SODIUM HYPOCHLORITE; DEBLOCKING | ABBOTT LABORATORIES (US) | 1996-12-03 | — | — | US | disclosed |
| US-5573922-A | COMPETITIVE POLYCLONAL ANTIBODY BINDING, TESTING WATER SAMPLES | BOEHRINGER MANNHEIM GMBH (DE) | 1996-11-12 | — | — | US | disclosed |
| US-5559210-A | STEROIDS AS IMMUNOGENS | ABBOTT LABORATORIES (US) | 1996-09-24 | — | — | US | disclosed |
| WO-1996014878-A2 | CALIXARENE CONJUGATES USEFUL AS MRI AND CT DIAGNOSTIC IMAGING AGENTS | MOLECULAR BIOSYSTEMS, INC. (US) | 1996-05-23 | — | — | WO | disclosed |
| EP-0712497-A1 | REAGENTS AND METHODS FOR THE DETECTION AND QUANTIFICATION OF TESTOSTERONE IN FLUID SAMPLES | Abbott Laboratories (US) | 1996-05-22 | — | — | EP | disclosed |
| US-5491071-A | LABELS; TEST KITS; IMMUNOASSAYS | ABBOTT LABORATORIES (US) | 1996-02-13 | — | — | US | disclosed |
| WO-1995004283-A1 | REAGENTS AND METHODS FOR THE DETECTION AND QUANTIFICATION OF TESTOSTERONE IN FLUID SAMPLES | ABBOTT LABORATORIES (US) | 1995-02-09 | — | — | WO | disclosed |
| EP-0622633-A2 | Immunological detection of triazine | Roche Diagnostics GmbH (DE) | 1994-11-02 | — | — | EP | disclosed |
| EP-0599325-A1 | B12 conjugates | Roche Diagnostics GmbH (DE) | 1994-06-01 | — | — | EP | disclosed |
| WO-1994002466-A1 | UNSYMMETRICAL MONO-3-NITRO BIS-NAPHTHALIMIDES AS ANTICANCER AGENTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1994-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11092594-B2 | Haptens, hapten conjugates, compositions thereof and method for their preparation and use | CRBN, AHR, RORB | ALDH1A1 2734/4885ATM 3688/4885TSHR 544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.